[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100656862":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":17,"studyPopulation":18,"armGroups":13,"interventions":13,"overallOfficials":19,"centralContacts":24,"locations":13,"responsibleParty":34,"collaborators":13,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":42,"eligibilityCriteria":43,"healthyVolunteers":38,"sex":44,"minAge":45,"maxAge":13,"enrollmentInfo":46,"targetDuration":13,"studyType":49,"phases":13,"briefSummary":50,"conditions":51,"keywords":13,"overallStatus":56,"whyStopped":13,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":13},{"fullName":5,"class":6},"Gruppo Italiano Malattie EMatologiche dell'Adulto","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Number of patients with venous thromboembolism event during hospitalization","Cumulative incidence of the first venous thromboembolism event from hospital admission to discharge or death","through study completion, an average of 2 years",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"CASE_ONLY","PROSPECTIVE","This is a prospective, observational cohort study designed to identify risk factors for venous thromboembolism (VTE) in patients with newly diagnosed acute leukemia (AL) at the time of first admission to a Hematology Ward. The study will be conducted within the GIMEMA network of Italian Hematology Centers.\n\nThe observation period for each patient will correspond to the duration of hospitalization, starting from the day of admission to the Hematology Ward, irrespective of whether antithrombotic therapy is prescribed.","The study will include patients with newly diagnosed acute leukemia at the time of first admission to a Hematology Ward.",[20],{"name":21,"affiliation":22,"role":23},"Marco Marietta, MD","Hematology Unit AOU Modena - Italy","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":13,"email":29},"Paola Fazi","CONTACT","+39 0670390522","gimema@gimema.it",{"name":31,"role":27,"phone":32,"phoneExt":13,"email":33},"Enrico Crea","+39 0670390514","e.crea@gimema.it",{"type":35,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100656862","real-world-assessment-of-venous-thromboembolic-risk-in-hospitalized-patients-with-acute-leukemia-100656862",false,"NCT07831668","Real World Assessment of Venous Thromboembolic Risk in Hospitalized Patients With Acute Leukemia","Real-World Assessment of Venous Thromboembolic Risk in Hospitalized Patients With Acute Leukemia (The ReVeAL Study of the GIMEMA Working Party on Hemostasis and Thrombosis)","ReVeAL","Inclusion Criteria:\n\n1. Age equal to or greater than 18 years of age\n2. New diagnosis of Acute Leukemia (APL, other AML, ALL) according to the current diagnostic criteria of the ELN 2022 for myeloid lineage (AML\u002FAPL) and ELN 2024 for lymphoid lineage (ALL)\n3. Hospitalization in a Hematology Ward lasting at least 2 days\n4. Signed informed consent\n\nExclusion Criteria:\n\n1. Ongoing therapeutic-dose anticoagulant treatment at the time of admission (i.e., dosage exceeding standard thromboprophylactic regimens)\n2. Diagnosis of venous thromboembolism (VTE) or major bleeding (MB) occurring within 48 hours of hospital admission","ALL","18 Years",{"count":47,"type":48},250,"ESTIMATED","OBSERVATIONAL","This is a observational study designed to identify risk factors for venous thromboembolism in patients with newly diagnosed acute leukemia at the time of first admission to a Hematology Ward.\n\nEach patient will be observed for the duration of hospitalization.",[52,53,54,55],"Acute Leukemia","Newly Diagnosed Acute Leukemia","Thromboprophylaxis","Thromboprophylaxis in Acute Leukemia","NOT_YET_RECRUITING","2026-09-15",{"date":59,"type":60},"2026-09-21","ACTUAL",{"date":62,"type":48},"2027-01",{"date":64,"type":48},"2029-01",{"name":5,"class":6}]